Dai-ichi Life Holdings’s ResMed RMD Stock Holding History

Dai-ichi Life Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,463	Closed	-$195K	–	614
2015 Q2	$195K	Hold	3,463	–	–	0.01%	579
2015 Q1	$249K	Sell	3,463 -770	-18%	-$50K	0.01%	547
2014 Q4	$237K	Hold	4,233	–	–	0.01%	547
2014 Q3	$209K	Hold	4,233	–	–	0.01%	595
2014 Q2	$214K	Hold	4,233	–	–	0.01%	593
2014 Q1	$189K	Hold	4,233	–	–	0.01%	601
2013 Q4	$199K	Hold	4,233	–	–	0.01%	595
2013 Q3	$224K	Buy	4,233 +2,605	+160%	+$126K	0.01%	588
2013 Q2	$73K	Buy	+1,628	New	+$77.2K	﹤0.01%	646

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dai-ichi Life Holdings's RMD Position: Q3 2015 in Review

Dai-ichi Life Holdings sold out of ResMed (RMD) in Q3 2015, closing a stake of 3,463 shares — an estimated $195K sold.

Dai-ichi Life Holdings first reported a position in RMD in Q2 2013 and held it in 9 quarters. The position peaked at $249K in Q1 2015. 313 funds tracked by Wall St. Rank hold RMD as of Q3 2015.

Dai-ichi Life Holdings reported no remaining ResMed position as of Q3 2015 after selling out during the quarter.
Dai-ichi Life Holdings sold 3,463 ResMed shares in Q3 2015, an estimated $195K.
Dai-ichi Life Holdings first reported a position in ResMed in Q2 2013 and held it in 9 quarters.
Dai-ichi Life Holdings's ResMed position peaked at $249K in Q1 2015.
313 funds tracked by Wall St. Rank held ResMed as of Q3 2015.

Based on Dai-ichi Life Holdings's 13F filing for Q3 2015, filed 10 Nov 2015.